Placebo News and Research

RSS

Improved gut diversity causes 50% reduction in autism symptoms

Changing the microbial environment in the gut in autistic children could substantially reduce the severity of the symptoms they experience, according to new research.

11 Apr 2019

Study sheds new light on long-term treatment with antidepressant drugs

A new study published in the current issue of Psychotherapy and Psychosomatics sheds new light on long-term studies with antidepressant drugs.

11 Apr 2019

Innovative drug delivery may alleviate Parkinson's symptoms and stop its progression

Parkinson's disease affects between 7 and 10 million people worldwide and the number of people diagnosed is soaring due to the ageing population.

10 Apr 2019

$FDA approves new osteoporosis drug for postmenopausal women with high fracture risk$

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).

9 Apr 2019

Acetaminophen can limit positive empathy for others, study shows

A new study by an Ohio University faculty member showed that acetaminophen limited positive empathy a person has for others while taking it.

8 Apr 2019

Anti-inflammatory medicine can be effective in treating people with depression

The World Health Organization calls depression one of the most serious mental disorders, and researchers around the world are trying to improve treatment of the disease.

8 Apr 2019

New research finds anti-inflammatory drugs to be ineffective to prevent Alzheimer’s

Researchers have known for decades that inflammation accompanies Alzheimer's disease brain lesions. Several early studies suggested that "super-aspirins" or Nonsteroidal anti-inflammatory drugs could help avoid the disease.

8 Apr 2019

NSAIDs ineffective for treatment or prevention of Alzheimer's disease

Researchers have known for decades that inflammation accompanies Alzheimer's disease (AD) brain lesions.

5 Apr 2019

New immune-based therapy eliminates HPV in one-third of women with cervical precancerous lesions

A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial.

4 Apr 2019

Gout treatment could potentially reduce complications accompanying metabolic syndrome

The drug colchicine, used to treat the arthritic condition gout, could potentially reduce complications accompanying metabolic syndrome, a combination of high blood pressure, high blood sugar and other conditions that increase the risk of heart disease and type 2 diabetes, according to researchers at the National Institutes of Health.

2 Apr 2019

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

29 Mar 2019

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

The U.S. Food and Drug Administration today approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA), with objective signs of inflammation. This is the first time that the FDA has approved a treatment for nr-axSpA.

28 Mar 2019

Gene transfer technique can combat diabetes-linked heart dysfunction

Researchers with the VA San Diego Healthcare System and the University of California San Diego have shown that a gene transfer technique can combat heart dysfunction caused by diabetes.

28 Mar 2019

Clinical trial examines medicinal cannabis as potential treatment for severe Tourette syndrome

A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with severe Tourette syndrome will be conducted by Wesley Medical Research, in Brisbane in Australia, with cannabis supply facilitated by Lambert Initiative for Cannabinoid Therapeutics at University of Sydney.

28 Mar 2019

Common drug may lead to obesity in offspring

Metformin,a common drug used to treat type 2 diabetes, is often used during pregnancy where the mother suffersfrom polycystic ovary syndrome.

27 Mar 2019

Male contraceptive pill crosses the human clinical trial hurdle

Birth control pills have been around for the past six decades but have been for use of women only. A team of researchers this week have announced the success of the first male birth control pill that could safely prevent pregnancy.

27 Mar 2019

FDA approves new drug to treat adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

27 Mar 2019

Placebo News and Research

Improved gut diversity causes 50% reduction in autism symptoms

Study sheds new light on long-term treatment with antidepressant drugs

Innovative drug delivery may alleviate Parkinson's symptoms and stop its progression

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

Acetaminophen can limit positive empathy for others, study shows

Anti-inflammatory medicine can be effective in treating people with depression

New research finds anti-inflammatory drugs to be ineffective to prevent Alzheimer’s

NSAIDs ineffective for treatment or prevention of Alzheimer's disease

New immune-based therapy eliminates HPV in one-third of women with cervical precancerous lesions

Gout treatment could potentially reduce complications accompanying metabolic syndrome

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

FDA approves treatment for adults with non-radiographic axial spondyloarthritis

Gene transfer technique can combat diabetes-linked heart dysfunction

Clinical trial examines medicinal cannabis as potential treatment for severe Tourette syndrome

Common drug may lead to obesity in offspring

Male contraceptive pill crosses the human clinical trial hurdle

FDA approves new drug to treat adults with relapsing forms of MS

Male contraceptive pill shown to be safe and tolerable in phase I trial

Treating women with thyroid antibodies with Levothyroxine do not increase live birth rate

Altering gut microbiome may be potential treatment option for PCOS

Industry Focus eBook - Life Science Microscopy (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News